Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681175/?tool=EBI |
| _version_ | 1797435713774419968 |
|---|---|
| author | Anouk W. M. A. Schaeffers Lot A. Devriese Carla H. van Gils Jan Willem Dankbaar Jens Voortman Jan Paul de Boer Marije Slingerland Mathijs P. Hendriks Ernst J. Smid Geert W. J. Frederix Remco de Bree |
| author_facet | Anouk W. M. A. Schaeffers Lot A. Devriese Carla H. van Gils Jan Willem Dankbaar Jens Voortman Jan Paul de Boer Marije Slingerland Mathijs P. Hendriks Ernst J. Smid Geert W. J. Frederix Remco de Bree |
| author_sort | Anouk W. M. A. Schaeffers |
| collection | DOAJ |
| first_indexed | 2024-03-09T10:51:15Z |
| format | Article |
| id | doaj.art-384294a837e14ac9ba26c18410221c79 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-03-09T10:51:15Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-384294a837e14ac9ba26c18410221c792023-12-01T05:31:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-011811Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocolAnouk W. M. A. SchaeffersLot A. DevrieseCarla H. van GilsJan Willem DankbaarJens VoortmanJan Paul de BoerMarije SlingerlandMathijs P. HendriksErnst J. SmidGeert W. J. FrederixRemco de Breehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681175/?tool=EBI |
| spellingShingle | Anouk W. M. A. Schaeffers Lot A. Devriese Carla H. van Gils Jan Willem Dankbaar Jens Voortman Jan Paul de Boer Marije Slingerland Mathijs P. Hendriks Ernst J. Smid Geert W. J. Frederix Remco de Bree Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol PLoS ONE |
| title | Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol |
| title_full | Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol |
| title_fullStr | Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol |
| title_full_unstemmed | Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol |
| title_short | Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol |
| title_sort | low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass the cislow study protocol |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681175/?tool=EBI |
| work_keys_str_mv | AT anoukwmaschaeffers lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT lotadevriese lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT carlahvangils lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT janwillemdankbaar lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT jensvoortman lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT janpauldeboer lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT marijeslingerland lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT mathijsphendriks lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT ernstjsmid lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT geertwjfrederix lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol AT remcodebree lowdosecisplatinweeklyversushighdosecisplatineverythreeweeksinprimarychemoradiotherapyinheadandneckcancerpatientswithlowskeletalmusclemassthecislowstudyprotocol |